Infection following total hip arthroplasty is a disastrous complication. Since its introduction in 1993, 2-stage reimplantation using an interval spacer of antibiotic-impregnated bone cement has been considered the gold standard for treatment of infected hip arthroplasties ([@CIT0013], [@CIT0018], [@CIT0015], [@CIT0002]).

It is generally believed that all components should be removed to eradicate the infection. However, an extended trochanteric osteotomy or cortical window is often required to remove a well-fixed femoral stem. This necessitates an extensive soft tissue dissection that devascularizes the proximal femur, which may lead to formation of sequestrum, causing recurrence of infection. If a circumferential bone ingrowth of a cementless stem acts as a barrier to intrusion of infected joint fluid and microorganisms, the infection could be treated without the removal of a well-fixed stem, and the risk of recurrent infection and implant failure would be lower.

There have been no reports on the results of stem-retaining 2-staged revision. We hypothesized that infection after hip arthroplasty could be treated without removal of a well-fixed cementless stem. We assessed the outcome of such a procedure in 19 patients.

Patients and methods {#ss1}
====================

From January 2005 to April 2010, 38 patients were operated with 2-stage revision to treat an infection after hip arthroplasty. A diagnosis of infection was made when there was drainage of pus, positive culture of aspirated ﬂuid and/or tissue, or histological evidence of infection ([@CIT0014], [@CIT0004]).

Our basic principle was 2-stage revision: removal of implants, debridement, and insertion of antibiotic-impregnated cement spacers in the first stage and implantation of new prostheses in the second stage ([@CIT0010]). In the first stage, we removed acetabular components, heads, cemented stems, and loose cementless stems without exception.

In cases of well-fixed cementless stems with radiographic evidence of bone ingrowth in the proximal one third or less and radiolucent lines around the distal portion of the stem ([@CIT0003], [@CIT0009]), we tried to remove the stem by making a cleavage between the stem and the proximal femur using thin osteotomes and gauges, and then pulling out the stem using a stem extractor. If this procedure did not work, we did not remove the stem. In cases where there was evidence of bone ingrowth along the entire length of the stem on the preoperative radiographs, we did not attempt stem removal because an extended osteotomy would be required to remove the stem with the risk of femoral fracture when the stem was being pulled out.

According to the above principle, 19 patients in 3 hospitals (7 men and 12 women, 19 hips) were treated without removal of their cementless stem; they were the subjects of this study. The stem was retained after a failed attempt at stem removal in 9 patients, while stem removal was not attempted in 10 patients.

Mean age at operation was 60 (31--85) years. 9 patients had undergone primary total hip arthroplasty, 7 patients bipolar hemiarthroplasty, and 3 patients revision hip arthroplasty. The mean time interval between the previous hip arthroplasty and the onset of symptoms of infection was 4 (0.5--12) years. Type of infection was defined as follows. An early postoperative infection was an infection that developed less than 1 month after the operation. A late chronic infection was one that developed 1 month or more after the index operation and which had an insidious clinical course. An acute hematogenous infection was associated with a documented or suspected antecedent bacteremia and was characterized by an acute onset of symptoms in the affected joint with the prosthesis ([@CIT0018], [@CIT0017]). The types of infection were late chronic infection in 10 patients and acute hematogenous infection in 9. 6 patients had been treated previously with antibiotics following incision and debridement elsewhere ([Table](#T1){ref-type="table"}). The mean preoperative Harris hip score was 60 (33--86) points.

###### 

Characteristics of patients who underwent two-stage reconstruction

  A    B      C                D                    E       F     G                    H    I              J
  ---- ------ ---------------- -------------------- ------- ----- -------------------- ---- -------------- ----------
  1    M/63   primary THA      AML stem             No      96    late chronic         6    *S. aureus*    69
  2    F/58   primary THA      AML stem             No      146   late chronic         13   Culture neg.   24
  3    F/31   stem revision    Corail stem          I & D   7     acute hematogenous   4    *S. aureus*    31
  4    M/39   primary THA      CLS stem             I & D   85    late chronic         8    CNS            39
  5    F/64   primary THA      Euroform stem        No      62    late chronic         24   *S. aureus*    24
  6    F/69   primary THA      Corail stem          No      6     acute hematogenous        Streptococci   10
  7    M/56   HA               CLS stem             I & D   216   late chronic         9    *S. aureus*    71
  8    F/36   primary THA      AML stem             I & D   39    late chronic         3    Culture neg.   100
  9    F/56   total revision   Bicontact stem       I & D   13    late chronic         15   Culture neg.   88
  10   F/37   primary THA      Gemini stem          No      173   late chronic         7    *S. aureus*    51
  11   M/53   primary THA      Corail stem          No      6     acute hematogenous   4    CNS            Recurred
  12   M/59   primary THA      Anatomical 6° stem   No      144   acute hematogenous   7    Streptococci   Recurred
  13   F/74   HA               Summit stem          No      9     late chronic         3    *S. aureus*    26
  14   M/85   HA               Summit stem          No      9     acute hematogenous   2    Enterococci    26
  15   F/74   HA               Summit stem          No      9     acute hematogenous   1    CNS            43
  16   M/51   cup revision     Bicontact stem       No      19    acute hematogenous   4    CNS            26
  17   F/84   HA               Bencox II stem       No      38    acute hematogenous   2    Culture neg    24
  18   F/79   HA               Soma stem            No      36    acute hematogenous        *S. aureus*    25
  19   F/77   HA               Wagner stem          I & D   72    late chronic         2    CNS            40

THA: total hip arthroplasty; HA: hemiarthroplasty; I & D: incision and debridement; CNS: coagulase-negative *Staphylococcus.*

A Patient no.

B Sex/age

C Type of index arthroplasty

D Previous stem

E Previous treatment

F Interval between index arthroplasty and first-stage revision (months)

G Type of Infection

H Interval between procedures (months)

I Etiological organism

F Duration of follow-up (months)

In 10 patients, the infecting organisms were identified from the drainage or aspirated fluid before the first stage of revision. Of the remaining 9 patients, the infecting organism was identified during the first-stage procedure in 5 ([Table](#T1){ref-type="table"}). The organisms identified were sensitive to at least 1 of the 3 antibiotics vancomycin, tobramycin, and cefotaxime, which were present in the impregnated cement spacer in the present study.

Operative and postoperative procedures {#ss2}
--------------------------------------

The ﬁrst procedure consisted of removal of the acetabular cup, liner, head, and other foreign materials such as wire; debridement of dead tissue; and insertion of a spacer. All operations were done using a posterolateral approach. During the procedure, several samples (at least 3) were sent for culture and sensitivity tests, and histological evaluation. Osteolytic lesions, if present, were curetted. The removed head was washed and immediately sterilized by autoclaving for 15 min and betadine-soaking.

For the hand-molded cement spacer, we used a so-called cocktail regimen of 3 antibiotics: vancomycin, tobramycin and cefotaxime ([@CIT0013], [@CIT0010], [@CIT0017], [@CIT0012]. 6 g of antibiotics (3 × 2 g) was pulverized and mixed thoroughly with 2 batches (80 g in total) of polymethylmethacrylate polymer (Simplex P; Stryker, Kalamazoo, Michigan). Then, the contents of 2 ampules of liquid monomer (40 mL in total) were added to the mixture. During the doughy stage of polymerization, the mixture was hand-molded into a hemispheric shape around the sterilized head, according to the diameter of the acetabular cup ([Figure 1A](#F1){ref-type="fig"}). The head in the constructed cement spacer was fitted onto the stem trunion. The bare area of the stem surface was covered with about 4 mm of antibiotic-impregnated cement ([Figure 1B](#F1){ref-type="fig"}). The cement-spacer cup was then reduced into the acetabulum. In 5 hips, small cement beads were implanted in dead spaces around the acetabulum and the proximal femur.

![A. The cement spacer was molded in the shape of a hemiarthroplasty prosthesis over the sterilized head, according to the size of the retrieved acetabular cup. B. The molded cement spacer was attached to the retained femoral stem.](ORT-84-260-g001){#F1}

A closed suction drainage was inserted, and it was removed 2--5 days after the operation when the amount of daily drainage was less than 50 mL. After the removal of the drain, the patients were permitted to walk, with weight bearing as tolerated.

Antibiotics for the postoperative treatment were selected on the basis of the sensitivities of the organism identiﬁed in the culture. Vancomycin was administered to 12 patients, cefazolin to 6, and ciproﬂoxacin to 1. These antibiotics were administered parenterally for 4--6 weeks after the first procedure. The interval between the 2 procedures was determined according to the improvement in clinical and laboratory findings of infection. Except for 1 patient (no. 15), who underwent the second-stage reconstruction 4 weeks after the first-stage procedure, the antibiotic-free interval was more than 1 month, and it was extended if the wound was slow to heal or ESR and/or CRP levels were slow to normalize ([Table](#T1){ref-type="table"}).

Of the 19 patients, 2 did not undergo second-stage reconstruction because their pain was tolerable and they were satisfied with the activity that they had obtained with the cement-spacer implantation.

In the remaining 17 patients, the second procedure was performed 1--24 months after the ﬁrst procedure. At the time of the second procedure, the spacer and antibiotic beads were removed and debridement of dead tissue was done. Several (at least 3) samples were sent for culture and sensitivity tests, and several synovial samples were examined for histology of frozen sections. During the second procedure, there was neither visible nor histological evidence of infection in any hips. No organisms were identiﬁed in culture of the samples obtained during the second-stage operation. 3 patients had bone-stock deﬁciency in the acetabulum, which was filled using morsellized bone grafts.

Cementless acetabular components and ceramic-on-ceramic articulation were used for the second-stage reconstruction. A secure press-fit was obtained in all hips.

The closed suction drain was removed 2 days after the second-stage operation, when draining volume was below 50 mL, and the patient was allowed to walk with 2 crutches for 1--3 months. Cefazolin was administered parenterally for 3 days after the second procedure.

Clinical and radiographic follow-up evaluations were performed at 2 and 6 weeks, at 3, 6, 9, and 12 months, and every 6 months thereafter. At the time of each follow-up, hematological studies were performed to check for recurrence of infection. Harris hip score was recorded ([@CIT0006]).

The fixation of the acetabular cup was assessed on AP and cross-table lateral radiographs using the method of [@CIT0011]. The fixation of the femoral component was assessed using the methods of [@CIT0003] and [@CIT0009]. The cup was considered loose when there was migration of \> 2 mm or a change in the abduction of \> 4°. The stem was considered definitely loose when there was a subsidence of \> 3 mm, and possibly loose when there was a complete radiolucent line along the entire porous-coated surface on both the AP and lateral radiographs. Postoperative 6-week radiographs were used as baseline and the final radiographic analysis was performed at the last follow-up.

Failure of treatment was deﬁned as a recurrence of infection.

The design and protocol of this multicenter retrospective study were approved by the institutional review boards at each center, who waived informed consent.

Results {#ss3}
=======

After the first-stage procedure, acetabular erosion was seen around the cement spacer on radiographs. It was between 2 mm and 8 mm, and did not cause any problems in implantation of the acetabular cup in the second-stage procedure.

2 patients who did not undergo second-stage reconstruction (nos. 6 and 18) were followed for mean 1.5 (1--2) years after the first-stage operation. They had no recurrence of infection. Hip pain was minimal or mild, and they could walk with a cane and perform their daily activities.

Of the 17 patients who underwent two-stage reconstruction, 15 had no recurrence of infection during the mean follow-up time of 4 (2--8) years after the second-stage operation ([Figure 2](#F2){ref-type="fig"}). The mean Harris hip score improved to 89 (65--94) points at the latest follow-up. 1 patient had an osteolytic lesion around the lateral wall of the acetabulum, but that was not progressive. There was no loosening of acetabular or femoral components.

![A. A 63-year-old man (patient no. 1) who had an infection after total hip arthroplasty, showing a bone-ingrown femoral stem. B. After the first-stage operation with an articulating cement spacer and retained femoral stem. C. 6 years after the second-stage reconstruction, with no evidence of implant loosening or osteolysis.](ORT-84-260-g002){#F2}

Infection recurred in 2 patients. 1 patient (no. 11), a 53-year old man who had diabetes mellitus and alcoholic liver cirrhosis, had a recurrence of infection 7 months after the second-stage reconstruction. He was treated with a repeat 2-stage operation without removal of the femoral stem. At the 18-month follow-up after the repeat surgery, the patient had no evidence of infection. He had no pain and could walk without any limp. The other patient (no. 12), a 61-year old man who had diabetes mellitus and hepatocellular carcinoma, had a recurrent infection 7 months after the first-stage operation. He underwent a Girdlestone arthroplasty and second-stage reimplantation but he died 3 months after the repeated reconstruction due to hepatic failure.

Discussion {#ss4}
==========

In the present study, the infection healed after initial treatment in 15 of 17 patients, which is similar to or higher than the rates reported in other series of 2-staged revision ([@CIT0007], [@CIT0015], [@CIT0012]. Infection was eliminated in 1 more patient after repeated two-stage revision.

One-stage revision is an attractive treatment for infected hip arthroplasty, because it can reduce morbidity, it reduces costs, and it avoids the technical difficulties of staged revision surgery. However, it is effective only at an early stage of infection by a low-virulence organism and should be performed with caution in selected patients ([@CIT0019], [@CIT0008], [@CIT0021]). A recent analysis, which compared 1-stage and 2-stage revisions to determine the treatment modality that would result in greater quality-adjusted life years using a decision analysis, favored the 1-stage revision ([@CIT0020]).

To avoid reconstruction in the presence of an unhealed infection, repeated aspiration of the joint before the second-stage operation has been recommended ([@CIT0016]). However, other studies have shown that repeat aspiration has a limited role in patients who have been treated with parenteral antibiotics ([@CIT0001], [@CIT0005], [@CIT0010]). We did not perform repeat aspiration before the second-stage operation.

The present study has several limitations. Firstly, although our patients were followed prospectively, the design of the study was a retrospective one---to test our treatment protocol with the hypothesis that it would be successful. Thus, we had no control group with other treatment options. Secondly, because of the small numbers of patients, we could not analyze data for patients stratified according to the virulence of the infecting organism, the type of infection, and the duration of infection. Thirdly, the stem-retaining method may leave a biofilm around the stem, which might mean eventual recurrence of infection.

In summary, we found that second-stage reimplantation after retention of bone-ingrown cementless stems could be an alternative treatment option for infected hip prostheses with well-fixed stems.
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